Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical Outcome

SIMPLE SUMMARY: Circulating tumor cells (CTCs) detected in cancer patients as single cells or in clusters are of prognostic value. There is currently no information concerning the co-expression of mesenchymal markers (important for metastasis) and PD-L1 (immune system suppressor) in CTCs of metastat...

Descripción completa

Detalles Bibliográficos
Autores principales: Polioudaki, Hara, Mala, Anastasia, Gkimprixi, Eleni, Papadaki, Maria A., Chantziou, Amanda, Tzardi, Maria, Mavroudis, Dimitris, Agelaki, Sofia, Theodoropoulos, Panayiotis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764288/
https://www.ncbi.nlm.nih.gov/pubmed/33322610
http://dx.doi.org/10.3390/cancers12123735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764288/
https://www.ncbi.nlm.nih.gov/pubmed/33322610
http://dx.doi.org/10.3390/cancers12123735

Ejemplares similares